Newer Oral Contraceptives and the Risk of Venous Thromboembolism-Reference-Cited by-同舟云学术

Newer Oral Contraceptives and the Risk of Venous Thromboembolism

Published:1998-03 Issue:3 Volume:57 Page:169-181
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Walker Alexander M

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference48 articles.

1. Oral contraceptives and venous thromboembolism (letter);Graham;Lancet,1995

2. Wood R, Botting B, Dunnell K. Trends in conceptions before and after the 1995 pill scare. Population Trends, 89. Office for National Statistics, London, 1997:5–12.

3. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study;Lancet,1995

4. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease;Lancet,1995

5. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives;J Clin Epidemiol,1995

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge, Attitude and Practices regarding Contraceptive Pill and Its Side Effects among Women in Jazan Region, Saudi Arabia;Clinics and Practice;2022-04-29

2. The Use of Randomized Controlled Trials in Pharmacoepidemiology;Pharmacoepidemiology;2019-10-18

3. Perioperative Management of Female Hormone Medications;Current Clinical Pharmacology;2018-03-22

4. Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database;PLOS ONE;2017-07-21

5. Instrumental variable analysis as a complementary analysis in studies of adverse effects: venous thromboembolism and second-generation versus third-generation oral contraceptives;Pharmacoepidemiology and Drug Safety;2016-01-08